JG
LOGC

Jefferies Group’s LogicBio Therapeutics, Inc. Common Stock LOGC Stock Holding History

Jefferies Group’s Portfolio LOGC Stock Details LOGC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-33,948
Closed -$308K – 1240
2020
Q3 		$308K Buy
+33,948
New +$308K ﹤0.01% 665
2019
Q4 		– Sell
-10,618
Closed -$115K – 2055
2019
Q3 		$115K Buy
+10,618
New +$115K ﹤0.01% 1531